Favorites Sign in
  1. Home
  2. Companies
  3. Neurocrine Biosciences
  4. Financial Ratios
  5. Operating Cycle
Neurocrine Biosciences logo
Neurocrine Biosciences NBIX
$ 173.86 2.83%
report update icon

Quarterly report 2026-Q3
added 11-02-2026

Neurocrine Biosciences Operating Cycle | NBIX

Annual Operating Cycle Neurocrine Biosciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
517 585 414 582 802 868 908 857 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
908 414 691

Quarterly Operating Cycle Neurocrine Biosciences

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
367 410 523 402 519 588 657 576 573 466 538 436 320 337 448 499 564 620 656 674 634 908 973 822 774 866 889 45.2 516 755 1.01 K 542 527 1.2 K 620 105 65.9 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.2 K 45.2 579

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
 		84.2 - - $ 11.3 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
 		213 - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
 		364 - -0.47 % $ 21 M usaUSA
Verastem Verastem
VSTM
 		455 $ 9.17 5.04 % $ 636 M usaUSA
Plus Therapeutics Plus Therapeutics
PSTV
 		71.1 - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
 		1.91 - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
 		49.8 - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
 		173 - -6.08 % $ 184 M chinaChina
Sangamo Therapeutics Sangamo Therapeutics
SGMO
 		4.14 - - $ 50.4 M usaUSA
Salarius Pharmaceuticals Salarius Pharmaceuticals
SLRX
 		382 - - $ 2.64 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
 		8.21 - - $ 826 K usaUSA
Vaxart Vaxart
VXRT
 		187 - -25.06 % $ 46.3 M usaUSA
XOMA Corporation XOMA Corporation
XOMA
 		23.6 - - $ 485 M usaUSA
Sesen Bio Sesen Bio
SESN
 		391 - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
 		164 - - $ 26.8 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
 		25.5 - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
 		392 - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
 		6.22 - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		104 - - - russiaRussia
Brickell Biotech Brickell Biotech
BBI
 		26 - -5.38 % $ 6.06 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
 		107 - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
 		18.6 - - $ 5.78 B niderlandNiderland
AbbVie AbbVie
ABBV
 		350 $ 294.72 0.32 % $ 521 B usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
 		33.4 $ 4.63 21.05 % $ 20 M israelIsrael
Axon Enterprise Axon Enterprise
AXON
 		98.8 $ 316.97 4.77 % $ 24.7 B usaUSA